Medical Transcription Billing Corp (NASDAQ:MTBC) CFO Bill Korn sold 9,664 shares of the business’s stock in a transaction on Wednesday, November 7th. The shares were sold at an average price of $5.52, for a total transaction of $53,345.28. Following the completion of the transaction, the chief financial officer now owns 167,750 shares in the company, valued at approximately $925,980. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Bill Korn also recently made the following trade(s):

  • On Monday, November 5th, Bill Korn sold 3,800 shares of Medical Transcription Billing stock. The shares were sold at an average price of $5.51, for a total transaction of $20,938.00.

MTBC stock opened at $5.03 on Friday. The firm has a market capitalization of $61.96 million, a P/E ratio of -38.69 and a beta of 1.58. Medical Transcription Billing Corp has a 12-month low of $2.17 and a 12-month high of $5.65.

Medical Transcription Billing (NASDAQ:MTBC) last posted its quarterly earnings results on Wednesday, November 7th. The technology company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.23) by ($0.02). Medical Transcription Billing had a negative net margin of 6.62% and a negative return on equity of 8.61%. The company had revenue of $17.05 million during the quarter, compared to the consensus estimate of $16.66 million. Equities analysts expect that Medical Transcription Billing Corp will post -0.5 EPS for the current year.

A hedge fund recently raised its stake in Medical Transcription Billing stock. Macquarie Group Ltd. raised its stake in Medical Transcription Billing Corp (NASDAQ:MTBC) by 59.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 100,401 shares of the technology company’s stock after purchasing an additional 37,501 shares during the period. Macquarie Group Ltd. owned 0.85% of Medical Transcription Billing worth $389,000 as of its most recent SEC filing. 5.93% of the stock is owned by hedge funds and other institutional investors.

Separately, HC Wainwright set a $6.00 target price on shares of Medical Transcription Billing and gave the company a “buy” rating in a report on Thursday. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $3.92.

COPYRIGHT VIOLATION NOTICE: “Insider Selling: Medical Transcription Billing Corp (MTBC) CFO Sells 9,664 Shares of Stock” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at

About Medical Transcription Billing

Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.

Recommended Story: Stock Symbol

Insider Buying and Selling by Quarter for Medical Transcription Billing (NASDAQ:MTBC)

Receive News & Ratings for Medical Transcription Billing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing and related companies with's FREE daily email newsletter.